Cargando…

Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis

SIMPLE SUMMARY: Approximately 15% of patients diagnosed with locally advanced malignant melanoma will relapse. Currently, anti-PD-1 and anti-CTLA4 antibodies and BRAF/MEK inhibitors are the mainstay of treatment of advanced, inoperable or disseminated malignant melanoma. A group of 52 patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szatkowska, Lidia, Sieczek, Jan, Tekiela, Katarzyna, Ziętek, Marcin, Stachyra-Strawa, Paulina, Cisek, Paweł, Matkowski, Rafał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997072/ https://www.ncbi.nlm.nih.gov/pubmed/35406444 http://dx.doi.org/10.3390/cancers14071672

Ejemplares similares

Non-Small Cell Lung Cancer Treatment with Molecularly Targeted Therapy and Concurrent Radiotherapy—A Review
por: Król, Katarzyna, et al.
Publicado: (2023)

The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy – A Single Institution Experience
por: Kordzińska-Cisek, Izabela, et al.
Publicado: (2020)

An analysis of clinical effectiveness of electrochemotherapy in the treatment of advanced metastatic malignant melanoma performed in the eastern part of Central Europe: a single-centre experience
por: Ziętek, Marcin, et al.
Publicado: (2022)

Brachytherapy in the Treatment of Non-Melanoma Skin Peri-Auricular Cancers—A Retrospective Analysis of a Single Institution Experience
por: Bilski, Mateusz, et al.
Publicado: (2022)

High Percentage of ADAM-10 Positive Melanoma Cells Correlates with Paucity of Tumor-Infiltrating Lymphocytes but Does Not Predict Prognosis in Cutaneous Melanoma Patients
por: Donizy, Piotr, et al.
Publicado: (2015)

The Influence of Tumor Microenvironment on Immune Escape of Melanoma
por: Simiczyjew, Aleksandra, et al.
Publicado: (2020)

Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-centre 4-year follow-up on a population of 709 patients
por: Ziętek, Marcin, et al.
Publicado: (2023)

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities
por: Simiczyjew, Aleksandra, et al.
Publicado: (2019)

Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)

Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance
por: Dratkiewicz, Ewelina, et al.
Publicado: (2021)

Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial Cancer
por: Cisek, Paweł, et al.
Publicado: (2018)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells
por: Pietraszek‐Gremplewicz, Katarzyna, et al.
Publicado: (2019)

Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: a report of 20 months experience
por: Ziętek, Marcin, et al.
Publicado: (2022)

Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy
por: Mazurkiewicz, Justyna, et al.
Publicado: (2021)

Melanoma stimulates the proteolytic activity of HaCaT keratinocytes
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022)

Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022)

Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
por: Grzegorczyk, Aleksandra, et al.
Publicado: (2023)

Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)

Interstitial HDR Brachytherapy in the Treatment of Non-Melanocytic Skin Cancers around the Eye
por: Cisek, Paweł, et al.
Publicado: (2021)

The report and analysis concerning the usefulness of basic telemedicine tools in the skin cancer diagnostic screening process during COVID-19 pandemics
por: Ziętek, Marcin, et al.
Publicado: (2022)

Fractal Dimension Analysis of Melanocytic Nevi and Melanomas in Normal and Polarized Light—A Preliminary Report
por: Popecki, Paweł, et al.
Publicado: (2022)

Melanoma in the elderly patient: a single institution retrospective analysis
por: Desiato, Vincenzo, et al.
Publicado: (2013)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

VSV based virotherapy in ovarian cancer: the past, the present and …future?
por: Orzechowska, Beata Urszula, et al.
Publicado: (2017)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

Possible Association between Suicide Committed under Influence of Ethanol and a Variant in the AUTS2 Gene
por: Chojnicka, Izabela, et al.
Publicado: (2013)

Inverse Association between Obesity Predisposing FTO Genotype and Completed Suicide
por: Chojnicka, Izabela, et al.
Publicado: (2014)

Systemic melanoma therapy at the end of life: A single institutional retrospective study in Japan
por: Yoto, Ayumi, et al.
Publicado: (2022)

Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
por: Donizy, Piotr, et al.
Publicado: (2017)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Subungual Melanoma: A Single Institution Experience
por: LaRocca, Christopher J., et al.
Publicado: (2021)

Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series
por: Stravodimou, Athina, et al.
Publicado: (2014)

Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
por: Orlandi, Armando, et al.
Publicado: (2021)

Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review
por: Bilski, M., et al.
Publicado: (2018)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
por: Kispál, Mihály, et al.
Publicado: (2022)

Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma
por: Formozo, A. A., et al.
Publicado: (2021)

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
por: Czarnecka, Anna M., et al.
Publicado: (2022)

Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4)
por: Kiepura, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpsahhr353jt4fid94p33m012m